ISSN 2149-2263 | E-ISSN 2149-2271 Home      
 
Volume : 19 Issue : 6
Current Issue Archive Popular Article Ahead of Print

   
Quick Search





 
The utility of high-sensitivity C-reactive protein levels in patients with moderate coronary lesions and gray-zone fractional flow reserve [Anatol J Cardiol]
Anatol J Cardiol. Ahead of Print: AJC-80148 | DOI: 10.14744/AnatolJCardiol.2018.80148  

The utility of high-sensitivity C-reactive protein levels in patients with moderate coronary lesions and gray-zone fractional flow reserve

Lin Li1, Qi-wei Liu1, Zhe Li4, Li Wang1, Jian-hong Wang2, Lei Song1, Bin Li3
1Department of Cardiology, Shandong Provincial Hospital Affiliated to Shandong University; Jinan-China
2Department of Hematology,Shandong Provincial Hospital Affiliated to Shandong University; Jinan-China
3Department of Surgery Center, Shandong Provincial Hospital Affiliated to Shandong University; Jinan-China
4Department of Health Examination, Jinan Central Hospital Affiliated to Shandong University; Jinan-China

Objective: It remains controversial whether patients with fractional flow reserve (FFR) values of 0.750.80 (gray-zone) should be treated with
percutaneous coronary intervention (PCI). This study aimed to evaluate the prediction of high-sensitivity C-reactive protein (hs-CRP) levels to
guide treatment selection in gray-zone patients.
Methods: This prospective interventional trial was conducted between January 2015 and March 2016. A total of 785 patients with stable angina
and single-vessel stenosis with moderate coronary lesions were admitted to hospital in this period. After measurement of hs-CRP levels,
coronary angiography, and FFR, gray-zone patients (n=308) were included in the study and were divided into four groups on the basis of a cutoff hs-CRP level of 3 mg/L and then on the basis of whether they underwent PCI or not. Patients in groups I (≥3 mg/L, n=70) and III (<3 mg/L, n=84) underwent PCI, whereas those in groups II (≥3 mg/L, n=70) and IV (<3 mg/L, n=84) were administered only drugs. Major adverse clinical events (MACEs) included cardiac death, nonfatal myocardial infarction (MI), target vessel revascularization (TVR), and PCI or coronary artery bypass grafting (CABG). These parameters were also evaluated during follow-up.
Results: The total Kaplan-Meier curves showed macrodistribution differences among the four groups (p<0.05). There was a significantly increased MACE incidence in group II compared with group I or IV (p=0.039 or 0.006, respectively), and an increased incidence in group I compared with group III (p=0.028). However, there were no differences in MACE incidence between groups III and IV (p=0.095) despite the fact that these patients received different treatments.
Conclusion: Among FFR gray-zone patients, hs-CRP level was a predictor of MACE and risk stratification could guide treatment selection. Increased hs-CRP levels (≥3 mg/L) are an indication for urgent PCI whereas normal levels (<3 mg/L) are an indication for delayed PCI treatment. Patients with identical FFR values could require different treatment.

Keywords: fractional flow reserve, gray-zone, high-sensitivity C-reactive protein (hs-CRP), major adverse cardiac events




Corresponding Author: Bin Li, China


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar




 
 
KARE Publishing | Copyright 2018 Turkish Society of Cardiology